Veradermics, Incorporated (MANE)

NYSE · Healthcare · Biotechnology
$119.52-3.92%As of 2026-11-22 · USD
Last session low $118.99Last session high $123.70
52-week low $32.0052-week high $156.63
Market cap
$5.04B
Sector
Healthcare

Market data and research context for informational purposes. Not investment advice.

Technical indicators

Indicators from the 2026-11-20 daily bar; Bollinger %B and the average rows compare the latest price with those values. Prices in USD.

IndicatorValueReading
RSI (14)42.0In the neutral range (30 to 70)
MACD (12, 26, 9)-0.21Below its signal line (2.84); histogram -3.05
Bollinger %B (20, 2)6%Inside the bands (117.39 to 153.54)
SMA 20135.47Price is 11.8% below
SMA 50124.71Price is 4.2% below
SMA 20097.39Price is 22.7% above
ATR (20)7.10% of priceAverage true range per day
52-week position70%In the upper part of the 32.00 to 156.63 range

About Veradermics, Incorporated

Veradermics, Incorporated, a clinical-stage biopharmaceutical company, focused on developing novel therapeutics for dermatologic and aesthetic conditions. The company develops treatments for Pattern Hair Loss affecting adults and children. The company's products include VDPHL01, an oral, non-hormonal treatment for men and women with PHL for chronic hair loss therapy.

Insider filings, 90 daysNo purchases and 2 sales (about $150.4M).

More in Biotechnology